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A new generation of antiepileptic drugs has emerged; however, one-third of epilepsy
patients do not properly respond to pharmacological treatments. The purpose of
the present study was to investigate whether time-restricted feeding (TRF) has an
anticonvulsant effect and whether this restrictive diet promotes changes in energy
metabolism and epigenetic modifications in a pilocarpine-induced seizure model. To
resolve our hypothesis, one group of rats had free access to food and water ad libitum
(AL) and a second group underwent a TRF schedule. We used the lithium-pilocarpine
model to induce status epilepticus (SE), and behavioral seizure monitoring was analyzed.
Additionally, an electroencephalography (EEG) recording was performed to verify the
effect of TRF on cortical electrical activity after a pilocarpine injection. For biochemical
analysis, animals were sacrificed 24 h after SE and hippocampal homogenates were
used to evaluate the proteins related to metabolism and chromatin structure. Our results
showed that TRF had an anticonvulsant effect as measured by the prolonged latency
of forelimb clonus seizure, a decrease in the seizure severity score and fewer animals
reaching SE. Additionally, the power of the late phase EEG recordings in the AL group
was significantly higher than the TRF group. Moreover, we found that TRF is capable of
inducing alterations in signaling pathways that regulate energy metabolism, including an
increase in the phosphorylation of AMP dependent kinase (AMPK) and a decrease in the
phosphorylation of Akt kinase. Furthermore, we found that TRF was able to significantly
increase the beta hydroxybutyrate (β-HB) concentration, an endogenous inhibitor of
histone deacetylases (HDACs). Finally, we found a significant decrease in HDAC activity
as well as an increase in acetylation on histone 3 (H3) in hippocampal homogenates
from the TRF group. These findings suggest that alterations in energy metabolism and
the increase in β-HB mediated by TRF may inhibit HDAC activity, thus increasing histone
acetylation and producing changes in the chromatin structure, which likely facilitates the
transcription of a subset of genes that confer anticonvulsant activity.
Keywords: anticonvulsant, pilocarpine, AMP kinase, Akt kinase, histone 3 acetylation, beta-hydroxybutyrate,
HDACs inhibition
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INTRODUCTION
Epilepsy is the third most common chronic brain disorder.
It affects 50 million people worldwide (Aroniadou-Anderjaska
et al., 2008). Although a new generation of antiepileptic drugs
has emerged, approximately 30% of epilepsy patients do not
respond to classical pharmacological treatment (Löscher et al.,
2013). For this reason, it is important to find new alternatives to
complement pharmacological therapy in drug-resistant patients.
To date, a variety of reports suggest that some metabolism-
based therapies, such as ketogenic diet (KD) or calorie restricted
(CR) diets, have an anticonvulsant effect (Bough et al., 2003;
Stafstrom and Rho, 2012). Recently, it has been suggested
that the beneficial effect of these diets may be produced by
means of a metabolic shift involving the activation of AMP-
activated protein kinase (AMPK), inhibition of the mammalian
target of rapamycin (mTOR) and overproduction of ketone
bodies (Wong, 2010; McDaniel et al., 2011; Yuen and Sander,
2014).
Time-restricted feeding (TRF) is a nutritional challenge that
limits food availability to a brief time during the waking phase
in mammals (Belet and Sassone-Corsi, 2010). This restrictive
model induces an increase in free fatty acids (FFA) before
feeding and an increase in peroxisomal markers, such as PPARα
and PPARγ (Rivera-Zavala et al., 2011), suggesting that it may
modulate a global metabolic shift that resembles the effects of
other metabolism-based therapies.
On the other hand, environmental inputs, such as nutrition,
are able to alter cell metabolism. In this sense, functional links
between metabolism and epigenetic control are beginning to
emerge (Sassone-Corsi, 2013). The regulation of gene expression
by epigenetic modifications can occur through a variety of
means. To date, the best characterized include DNAmethylation,
non-coding RNAs and histone posttranslational modifications
(Hullar and Fu, 2014).
Histone posttranslational modifications, such as acetylation,
occur at specific lysine residues and have been correlated
with transcriptional activation (Sassone-Corsi, 2013). Histone
deacetylases (HDACs) are enzymes that elicit the induction
of repressive chromatin using specific metabolites, such as
nicotinamide adenine dinucleotide (NAD+), whose availability
dictates the efficacy of the enzymatic reaction (Katada
et al., 2012). Interestingly, it has recently been shown that
β-hydroxybutyrate (β-HB), a ketone body produced during
fasting or starvation conditions, act as an endogenous inhibitor
of HDACs, thus linking metabolism with gene expression
(Shimazu et al., 2013).
In spite of these findings, there are no reports showing that
TRF may produce beneficial effects, such as those of KD and CR,
in an acute seizure model. For this reason, the purpose of this
study was to determine whether TRF induces a metabolic shift by
activating the energy sensor AMPK, inhibiting the Akt signaling
pathway and producing epigenetic modifications that are capable
of diminishing seizure susceptibility. Here, we report that TRF
had anticonvulsant effects observed as prolonged latency to first
seizure, a decrease in the seizure score, and a diminished number
of animals that reached status epilepticus (SE). Additionally, a
reduction in the power of the late phase electroencephalography
(EEG) recordings in the TRF group was significantly greater than
that in the AL group. Furthermore, TRF produced an increase in
the β-HB concentration, activation of AMPK, inhibition of Akt
kinase and increased histone 3 (H3) acetylation. These findings
suggest that activation of the AMPK signaling pathway together
with an increase in ketone bodies could mediate the acetylation
of H3, thus contributing to the transcription of a subset of genes
conferring anticonvulsant activity.
MATERIALS AND METHODS
Time-Restricted Feeding Schedule and
Pilocarpine-Induced Seizure Model
Ninety-five young adult male Wistar rats (8 weeks of age)
weighing approximately 220 g obtained fromHarlan laboratories
(USA) were used and maintained under constant temperature
conditions (25◦C) and a 12 h light/12 h dark cycle. Animals
were fed with a standard diet of Lab Diet Rodent Laboratory
Diet 5001 pellets (PMI Nutrition International, Inc., Brentwood
MO) and water ad libitum (AL, control and pilocarpine groups)
or underwent the time-restricted feeding (TRF and TRF plus
pilocarpine groups) schedule described by Rivera-Zavala et al.
(2011). Briefly, TRF consisted of allowing rats to feed freely
for only 2 h daily for 20 days, and after this period of time,
we proceeded to perform the acute seizure model at day 21.
For the acute seizure model, we chose the lithium-pilocarpine
model because it is one of the most widely used models to
induce SE and is an excellent model that resembles human
temporal lobe epilepsy (Lemos and Cavalheiro, 1995). Animals
were first injected with lithium-chloride (3 mEq/kg, i.p.) at day
20; 18 h later, animals received a scopolamine methyl nitrate
injection (1 mg/kg, s.c.) 30 min prior to minimize the peripheral
cholinergic effects of pilocarpine. Pilocarpine was administered
(60 mg/kg, s.c.) to induce SE, and the latter was maintained for
90 min; immediately afterwards, animals received an injection
of diazepam (ValiumTM, 5 mg/kg i.m.) to stop the seizures.
The same procedure was performed for control animals that
did not receive a pilocarpine injection but rather received a
saline (0.9%) injection (Figure 1A). It is important to mention
that SE was induced after 6 h of fasting in AL-pilocarpine
rats and ≈ 22 h fasting in TRF-pilocarpine rats to avoid any
changes in metabolism; both AL- and TRF-pilocarpine animals
received a saline solution injection to avoid dehydration. Twenty-
four hours after the pilocarpine injection, experimental animals
were sacrificed with an overdose of sodium pentobarbital (26
mg/kg) to perform biochemical analyses. All experiments from
the present study were approved by the Ethical Committee of the
School of Medicine at UNAM following all of their statements to
minimize animal suffering.
Physical/Biochemical, Food Intake,
Glucose Tolerance, Brain and Liver Weight
Measurements
The food intake and body weight from each animal were
monitored daily, and both blood glucose and the β-HB
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FIGURE 1 | Influence of the time-restricted feeding (TRF) model on body weight, food intake, glucose, and β-hydroxybutyrate in the fasted/refed
state and the ratio among kilocalorie consumption and basal metabolic rate (BMR) in rats. (A) Schematic representation of the experimental procedure of
the dietary schedule and status epilepticus (SE) induction. Body weight of TRF rats showed a significant decrease at all time points measured (B); moreover, there is
a reduction in food intake and the ratio of caloric intake/metabolic rate compared with that of ad libitum (AL)-fed animals (D,F). Regarding biochemical parameters,
the blood glucose concentration showed no significant difference in the fasted state; however, AL-fed rats showed an inability to metabolize glucose at 15 and 20
days, which does not occur in TRF animals (C). Interestingly, the blood β-hydroxybutyrate concentration was high during the TRF schedule and it was maintained
even in the refed state, even though it is lower than during the fasted state (E). Data are expressed as the mean ± SD from each determination (n = 30, ∗∗p < 0.01;
∗∗∗p < 0.001).
concentration were measured using a digital monitor system
(Optium Xceed glucometer, Abbott USA) with specific glucose
and β-HB strips at 5, 10, 15 and 20 days. For blood
sampling, animals from the AL group were fasted for 6 h
before measurement and the TRF group was measured before
feeding with chow (≈ 22 h fasting). For glucose tolerance, we
performed an additional experiment consisting of measuring the
blood glucose in fasted rats, and then, animals were injected
intraperitoneally with a glucose solution (refed rats, 1 g/kg
body weight) and their blood glucose was measured again
after 60 min. The same experimental procedure was carried
out for the β-HB measurement to verify whether the β-HB
levels remained or decayed after receiving a glucose injection.
In addition, we calculated the ratio of the daily caloric intake
(kcal/day) consumed for each animal from the AL and TRF
groups and divided by basal metabolic rate (BMR) using an
allometric scaling formula (BMR = 70M0.75, where M means
mass) to verify whether the TRF schedule could have an effect on
growth in animals. Finally, the brains and livers from the AL and
TRF groups were perfused with saline, dissected and weighed to
examine whether dietary restriction could affect the size of each
organ.
Latency to the First Seizure, Seizure Score
and Number of Animals that Reached
Status Epilepticus
After administration of pilocarpine, animals were continuously
video monitored for seizure activity for at least 5 h by an
investigator-blinded to the treatment who then scored the
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behavioral seizures. Latency to the first seizure was measured
in minutes until the first forelimb clonus appeared, and the
seizure score and the number of rats that reached SE were also
analyzed. The behavioral seizures induced by pilocarpine were
scored according to amodified version of the Racine scale (Bough
et al., 2002). The latency to first seizure, seizure severity score,
and individuals with SE were averaged across animals in each
group.
Western Blot Analysis
Experimental animals were sacrificed with an overdose of
anesthesia and rat brains were dissected as quickly as
possible. Immediately afterwards, hippocampi were obtained
and fractioned into cytoplasmic and nuclear extracts using a
subcellular fractionation kit (Thermo Scientific, USA) following
the manufacturer’s instructions. Protein extracts were quantified
by a BCA assay kit (Pierce, USA), and 60 µg of protein
was loaded on 12 or 15% SDS-PAGE gels. Proteins were
transferred to a PVDF membrane in a semi-dry electrophoretic
transfer system (BioRad, USA). Then, membranes were rinsed
with Tris-buffered saline (TBS) and blocked with a solution
containing 5% non-fat dry milk in TBS-Tween 20 0.1% (TBST)
overnight at 4◦C. Blots were probed with rabbit polyclonal anti-
pAMPK (Thr172; 1:1000, Cell Signaling Technology, AB 2535),
polyclonal anti-pAkt (Ser473; 1:1000 Cell Signaling Technology,
AB 4060) and the H3 acetylation at lysine residues 9 and 14
(H3K9ac and H3K14ac; 1:1000, Cell Signaling Technology, AB
9649 and AB 7627, respectively) in TBST overnight at 4◦C.
After three rinses with TBST for 5 min each, membranes
were incubated with a goat anti-rabbit IgG secondary antibody
(1:2500 Cell Signaling Technology, AB7074) for 2 h at room
temperature followed by three rinses with TBST for 5 min
each. The band signal was detected by a chemiluminescence kit
(Millipore, USA) on AmershamHyperfilm. For loading controls,
rabbit polyclonal antibodies against total AMPK, Akt, and H3
(1:1000, Cell Signaling Technology, AB 5831, AB 4691 and AB
4499, respectively) were used. Densitometry measurements of
the detected bands images were taken with a CCD camera
(DNR Bio-Imaging Systems), and the analysis was carried out
with MCID image analysis software (InterFocus Imaging Ltd.,
Cambridge, UK).
Histone Deacetylase Activity Assay
Protein nuclear extracts from hippocampal homogenates were
quantified by a BCA assay kit (Pierce, USA), and 80µg of protein
was used tomeasureHDAC activity (specifically class I type) with
a histone deacetylase assay kit (Sigma-Aldrich, USA) following
the manufacturer’s instructions. All samples were analyzed in
duplicate, and the total HDAC activity was calculated using the
following formula:
Activity(ng/h/mg)
= [RFU (control − blank) − RFU (sample − blank)]
slope× h× protein amount added
where RFU indicates (relative fluorescence units) the slope
(HDAC concentration) and h (initial incubation time).
Electroencephalography (EEG) Recording
and Frequency Analysis
Ten rats (n = 5 each) were chronically implanted under
ketamine/xylazine mixture anesthesia (4 ml/kg). For EEG
recording, a stainless steel screw electrode was threaded into
the bone epidurally, 1.5 mm lateral and 2 mm posterior to
the bregma. Two additional stainless steel screws driven into
the bone above the frontal sinus, and the cerebellum served
as the reference to ground electrodes. All three screws were
secured to the skull with dental acrylic. Seven to ten days were
allowed for recovery. EEG signals were recorded monopolarly
in freely moving rats from inside a shielded chamber. The
EEG recordings were measured with a P15 preamplifier (Grass
Instruments Company, USA), amplified 2000 times, filtered
(0.1–100 Hz) and digitized at 20 kHz with an analog-to-
converter (Micro-1401, CED, Cambridge, UK) and then saved
onto the hard drive of a computer. The EEG signals were
analyzed off-line with Spike2 (CED) and MatLab software; the
data were first band-pass filtered (FIR filter, 1–50 Hz and
51–100 Hz). Subsequently, a Hanning window was applied on
blocks of 8192 sample points (bin size 0.12 Hz) of EEG data
before the power spectra were calculated using Fast Fourier
Transformations (FFT). The total spectral power between 1 and
50 Hz and between 51 and 100 Hz analyses were assessed from
artifact-free EEG segments (3 min). The power spectra obtained
by using FFT were divided into 1.25–4.5 Hz, 4.75–6.75 Hz,
7.0–9.5 Hz, 9.75–12.5 Hz, 12.75–18.5 Hz, 18.75–35.0 Hz,
35.5–42.0 Hz, and 51.0–100 Hz frequency bands. The normalized
power bands below 42 Hz exhibited similar temporal patterns,
but were significantly different compared to the normalized
power spectrum of 51.0–100 Hz. Therefore, power analysis was
conducted in the bands between 1–50 Hz and 51–100 Hz.
Statistics
The values of relative optical units were examined to test the
normality of a data set. Then, a two-tailed unpaired Student’s
t-test and Mann-Whitney U test were used for the body weight,
food intake, brain and liver tissue weight, behavioral analysis
and EEG recording frequency analysis. One-way ANOVA with
Tukey’s post hoc test were used for data from western blots
and HDAC activity tests, while repeated measures ANOVA with
Bonferroni’s post hoc test was used for the blood glucose and
β-HB levels. Pearson’s or Spearman’s correlation test were used
for correlation among the seizure latency/score vs. β-HB levels.
In addition, Chi squared and Fisher’s exact test were applied
for the qualitative results (number of animals that reach SE or
not). All statistical tests were performed using GraphPad Prism
statistics software version 5 (GraphPad Software, San Diego, CA,
USA) and p < 0.05 was considered statistically significant.
RESULTS
Metabolic Shift Induced by a
Time-Restricted Feeding Model
To establish whether the TRF model induces a general metabolic
shift, we measured the body weight, food intake, blood glucose
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and β-HB concentration. As we observed, animals that were
subjected to the TRF schedule significantly lost weight at day 2
and continued up to day 11. Surprisingly, animals began to
gain weight at day 15 and recovered to almost their starting
weight at the end of the dietary schedule; however, compared
with the control fed AL, all weights were significantly lower
(Figure 1B, p < 0.001). According to food intake, rats subjected
to TRF consumed less food (5.8 gr) within the first 3 days
compared to AL animals (21.3 gr; Figure 1D, p < 0.001), and
this result correlates with dramatic weight loss (Figure 1B).
At day 4, animals started to consume more food (13 gr) and
began to stabilize their weight. However, food consumption
was significantly lower compared to the AL rats throughout
the dietary schedule (Figure 1D). To verify whether the TRF
schedule could have an effect on animal growth, we calculated
the ratio of the daily caloric intake (kcal/day) consumed by
each animal from the AL and TRF groups and divided this
by the BMR. In this regard, we observed that in the first 2
days, the animals that followed the TRF schedule had a caloric
intake below their metabolic rate; however, ≈ at day 5, these
animals increased their caloric intake and maintained this ratio
throughout the dietary schedule. Conversely, the AL group
tended to eat three times more calories needed to maintain their
BMR (Figure 1F).
Interestingly, even though a slight decrease was observed in
the blood glucose concentration of TRF animals after 5, 10,
15 and 20 days, there was no significant difference compared
with AL-fed animals in a fasting condition (Figure 1C). In
addition, we studied possible alterations in glucose tolerance after
an injection of a glucose solution (re-fed condition) in fasted
rats in both experimental groups. In this regard, glucose from
the AL-fed animals was significantly higher at day 15 and 20
compared with that of the group that followed the TRF schedule.
Furthermore, the blood β-HB concentration was significantly
higher in the TRF group at all-time points of the dietary schedule
compared with that of AL-fed animals (Figure 1E, p < 0.001).
Surprisingly, after refed conditions, β-HB levels remained higher
in TRF rats compared with that of AL-fed animals. Nevertheless,
the levels of this ketone body were lower compared to TRF rats
in a fasted state.
Ultimately, to investigate the effect on organ weight, such
as the brain and liver in animals submitted to the TRF
schedule, we weighed both organs in each group of animals.
We found a slight decrease in the brain weight of TRF
rats (1.76 ± 0.09 g, n = 8) compared with AL animals
(1.84 ± 0.11 g); however, such a decrease was not significant
(Figures 2A,C). Conversely, livers from TRF rats showed
a statistically significant decrease (8.98 ± 0.92 g, n = 8,
p < 0.001) compared with those of AL-fed rats (16.08 ±
1.05; Figures 2B,D). These data demonstrate that the TRF
schedule has an effect on weight loss and food intake and
that it influences the overproduction of ketone bodies, as
measured by β-HB. Moreover, high β-HB levels remained in
TRF animals after glucose injection indicating that dietary
schedule can modulate alternative energy metabolic pathways
and maintain the production of ketone bodies despite glucose
availability.
FIGURE 2 | TRF model decreases liver weight, but not brain weight. At
the end of the dietary schedule, the mean liver weight of TRF rats showed a
significant decrease compared with that of AL-fed animals (B,D); on the other
hand, brain weight was not influenced by the time restricted feeding model
(A,C). Data are expressed as the mean ± SD from each determination
(n = 10, ∗∗∗p < 0.001).
Time-Restricted Feeding Induces Changes
in Metabolism-Related Signaling Pathway
Components
It is well known that AMPK and Akt kinases are the main
components of the signaling pathways involved in metabolic
regulation and cell growth (Burkewitz et al., 2014; Guo, 2014).
In this regard, homogenates from the TRF hippocampus
showed a statistical increase in AMPK phosphorylation (n = 8,
p < 0.001) and a significant decrease in Akt phosphorylation
compared with that of AL-fed animals homogenates (n = 8,
p < 0.001; Figures 3A,B), indicating that TRF regulates the
activity of metabolism-related signaling pathway components.
To corroborate similar changes in peripheral tissues, we
performed western blot analysis in liver homogenates. Our
results showed that there was a statistically significant increase
in AMPK phosphorylation and a significant decrease in
Akt phosphorylation in liver homogenates from TRF rats
compared with those of AL-fed animals (Figures 3C,D). These
results indicate that the TRF schedule can induce changes in
metabolism-related signaling pathways in the central nervous
system and peripheral organs, such as liver tissue.
Anticonvulsant Effect of Time-Restricted
Feeding in the Pilocarpine-Induced Seizure
Model
To examine the anticonvulsant activity of the TRF schedule
in an acute seizure model, we performed behavioral and EEG
recordings. All of the control animals fed AL treated with
pilocarpine had generalized seizures lasting at least 2 h. The
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FIGURE 3 | Effects on metabolic related signaling pathways during TRF schedule in brain and liver tissues. Immunoblots from hippocampal rat brain
homogenates that followed dietary restriction revealed a significant increase in AMP dependent kinase (AMPK) phosphorylation at threonine Thr172 content
compared with that of their respective AL-fed control animals. Conversely, homogenates from TRF rats showed a significant decrease in Akt phosphorylation at
serine 473 compared with that of their AL-fed controls (A,B). Additionally, similar results were obtained in liver homogenates, where there was an increase in AMPK
phosphorylation and a decrease in Akt phosphorylation (C,D). Samples were normalized with total AMPK or Akt. Bar charts are the semiquantitative optical densities
of immunostained bands (B). Data are expressed as the mean ± SD from each determination (n = 8, ∗∗∗p < 0.001).
mean latency to the first forelimb clonus was 26.53 ± 5.02 min
(Figure 4A); the mean seizure score was 4.66± 1.15 (Figure 4B),
and 27 of 30 animals reached SE (Figure 4C, n = 30). In addition,
seven of these animals died within 24 h. Conversely, the TRF
group showed a significant increase in latency to forelimb clonus
seizure of 37.93 ± 6.60 min (n = 30, p < 0.001; Figure 4A) and
a significant decrease in the mean of seizure score (3.53 ± 0.82,
n = 30, p < 0.001; Figure 4B). Most importantly, only 19 out of
30 animals reached SE and only two out of 30 died within 24 h,
thus improving survival (n = 30, p < 0.05; Figure 4C).
A High Level of β-Hydroxybutyrate
Positively Correlates with Seizure Latency
and Negatively in the Seizure Severity
Scale
Additionally, to determine whether changes in β-HB
concentrations are involved in anticonvulsant activity, we
measured the β-HB concentration in the blood before seizure
induction (see above). In this regard, we found that an
increase in seizure latency is positively correlated with the
blood β-HB concentration (n = 10, R2 = 0.772, p < 0.05).
Conversely, we found that the seizure severity score was
negatively correlated with high β-HB levels (n = 10, R = 0.6407,
p < 0.01), suggesting that the blood β-HB concentration has an
important role in the anticonvulsant activity mediated by TRF
(Figure 4D).
Time-Restricted Feeding Decreases the
Power of EEG Seizures in the
Pilocarpine-Induced Seizure Model
In addition, we recorded EEGs from 10 rats (n = 5 each) to study
the power spectra of the seizures. The mean power differences
between 3 min intervals were tested, and one from each data
point in the AL and TRF groups were compared for 90 min after
pilocarpine injection (Figures 5C,D). Fast Fourier Transform
analysis (FFT) of EEG recordings revealed a significant increase
in the total spectrum, measured as the total power in µV2/H in
both groups after pilocarpine administration. The time course
of the power spectrum in both groups (AL and TRF) showed
that after a latency period (from 21–48 min), an increase until
a maximum peak power for several thousand times occurred
and then gradually declined to a nonzero level. There were
no significant differences between the mean latency of EEG
seizure in the data from the spectral power obtained with a
broadband of 1–50 Hz (Figure 5C) and 51–100 Hz (Figure 5D)
filtering. However, the time to the peak of the power spectrum
of the broadband 1–50 Hz in the AL group was significantly
longer than that in the TRF group (p < 0.05). At approximately
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FIGURE 4 | TRF inhibits seizure susceptibility measured by behavioral analysis. TRF animals showed an increased latency (A), a significant decrease in the
mean seizure score (B) and a smaller number of animals reaching status epilepticus (SE) (C) compared with that of AL-fed rats. Moreover, there was a positive
statistically significant correlation among high β-HB levels and decreased latency to the first seizure and a negative correlation between high β-HB levels and a
reduction in seizure score in rats subjected to TRF (D). Data are expressed as the mean ± SD from each determination (n = 30 for behavioral analysis, ∗p < 0.05;
∗∗∗p < 0.001; n = 10 for Pearson’s or Spearman’s correlation test, p < 0.05 and p < 0.01, respectively).
90 min after the application of pilocarpine, the power of the
TRF group was significantly lower than that of the AL group
(Figures 5C,D). An illustration of a representative EEG of AL
and TRF after pilocarpine injection is shown (Figures 5A,B,
respectively).
Time-Restricted Feeding Inhibits Histone
Deacetylase Activity in Hippocampal
Nuclear Extracts
Previous reports described that β-HB could act as an endogenous
histone deacetylases class I inhibitor (Shimazu et al., 2013). To
determinate whether the β-HB levels produced by TRFmay exert
a similar action in hippocampal homogenates, we performed a
total HDAC activity assay. As seen in Figure 6A, animals fed
AL had a total activity value of 0.104 ± 0.036 ng/h/µg; however,
animals that followed the TRF schedule presented a reduced
of activity value of 0.030 ± 0.017 ng/h/µg (n = 4, p < 0.05),
indicating an important reduction of HDAC activity compared
with that of AL-control animals. On the other hand, SE-induced
animals fed with AL had a similar activity value (0.103 ±
0.043 ng/h/µg, n = 4, p < 0.05) as control animals. In addition,
pilocarpine-injected animals that followed the TRF schedule
had a decrease in the activity value (0.030 ± 0.030 ng/h/µg)
corresponding to a reduction in HDAC activity compared with
AL-pilocarpine-injected animals (Figure 6D). These results are
compatible with the hypothesis that the β-HB levels produced
by TRF are able to regulate HDAC activity in hippocampal
homogenates and indicated that feeding restriction may exert an
inhibitory effect, as previously described in other in vitro and in
vivomodels (Shimazu et al., 2013).
Dietary Restriction Induces Epigenetics
Changes by Increasing H3 Acetylation in
the Hippocampal Nuclear Fraction
To demonstrate whether the TRF model induces epigenetic
modifications (principally by an inhibitory effect on HDAC
activity), we measured the H3 acetylation protein levels in
the hippocampal nuclear fraction by immunoblotting using
antibodies that recognize acetylated H3 at lysine 9 and
lysine 14 (H3K9ac and H3K14ac, respectively). As observed in
Figures 6B,C, the content of H3 acetylation in hippocampus
homogenates from animals that followed the TRF schedule
before seizure induction showed a statistically significant
increase in both H3K9ac and H3K14ac epitopes compared
with that of AL-fed animals plus pilocarpine or AL-fed control
animals (n = 8, p < 0.001; Figures 6E,F). These results confirm
that the TRF schedule might be able to induce epigenetic tags by
increasing the β-HB concentration via their inhibitory action on
HDAC activity.
DISCUSSION
Dietary treatment for epilepsy has likely been used since ancient
times (Yuen and Sander, 2014). The use of metabolism-based
diets for the treatment of refractory epilepsy, mainly the classical
KD and its variants, is relatively common (Patel et al., 2010).
Unfortunately, these diets can produce early onset complications,
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FIGURE 5 | Representative electroencephalography (EEG) signal and FTT analysis from AL and TRF pilocarpine-injected rats. The upper tracings show
typical EEG recordings before administration of pilocarpine in AL rats (A) and TRF rats (B) (n = 5 each). The numbers at the left of each record indicate the time after
the application of pilocarpine. Plots of the mean power spectra as a function of time for the EEG recording taken from rats injected with pilocarpine. Power values
were calculated as the percent of the 45 min baseline power recorded before pilocarpine injection, assigned as a value of 100% (data not shown). (C) Fast fourier
transformations (FFT) of the 1–50 Hz frequency spectrum. (D) FFT of the 50–100 Hz frequency spectrum. The red symbol represents the mean data from AL rats
and the blue symbol represents the mean values from TRF rats. AL: (1) Baseline period, (2) 32, (3) 65, and (4) 75 min, time after the application of pilocarpine and
TRF: (1) Baseline period, (2) 15, (3) 40, and (4) 75 min, time after the application of pilocarpine. Data are expressed as the mean ± SEM (∗p < 0.05).
such as hypoglycemia, loss of body weight, ketosis, metabolic
acidosis and late-onset complications, including renal stones and
hypocarnitinemia (Kang et al., 2004). Nevertheless, the KD has
been widely used to control seizures in children with epilepsy and
with relative success in adolescents and adult patients (Hallböök
et al., 2007; Nei et al., 2014).
Caloric restriction (CR) produces a range of metabolic and
biochemical changes, including reduced glucose concentration,
formation of ketone bodies and increased AMP-activated protein
kinase activity (Maalouf et al., 2009; Burkewitz et al., 2014; Longo
and Mattson, 2014; Yuen and Sander, 2014). In this regard, the
present study demonstrated that TRF produces similar metabolic
changes, such as an increase in the blood β-HB concentration.
Furthermore, we found that after 2 days on the TRF schedule,
animals presented with a significant reduction in body weight
compared with that of AL-fed animals. Most importantly, at
day 5, animals that followed the TRF schedule had a reduction
of 10% of their body weight; however, this group tended to
recover their weight at day 15, confirming that thismodel induces
body weight loss, as has been previously described (Amigo and
Kowaltowski, 2014). Interestingly, a similar result in body weight
loss was observed in young rats subjected to a 15% of CR schedule
for 30 days (Phillips-Farfán et al., 2015), suggesting that both
diets may have similar effects. Such a drastic weight reduction
can be correlated with a decrease in food intake, as observed in
the TRF model during the early days of the study. Surprisingly,
TRF animals began to increase their food consumption and gain
weight as the study progressed. Nevertheless, food intake and
body weight were lower compared to AL-fed rats. Regarding
blood glucose levels, there were no significant changes between
the AL and TRF groups, which showed similar results to other
dietary models (Phillips-Farfán et al., 2015). However, in glucose
tolerance experiments, TRF-subjected animals seemed to better
metabolize glucose than AL-fed animals at 15 and 20 days,
suggesting that glucose metabolism in TRF animals is more
efficient or is not altered as in AL-fed animals. In this regard,
it has been described that a short-term CR (21 days) improves
glucose homeostasis in 1 and 2 years-old rats and that this
beneficial effect involves AMP-activated protein kinase (Pires
et al., 2014).
Regarding the evaluation of seizure behavior, the TRF
schedule produced a prolonged latency as well as a decrease in
the seizure severity score, and fewer animals reached SE after
pilocarpine injection. Indeed, such results were consistent with
a previous report where intermittent fasting had positive effects,
such as a greater number of surviving animals, a fewer number
of animals that reached SE and a reduction of the number of
animals that became epileptic (Parinejad et al., 2009).
Electrophysiologically, the initial part of the EEG response
and the onset/peak of the EEG between TRF and AL animals
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FIGURE 6 | TRF promotes epigenetic changes in the hippocampus through inhibition of HDAC activity and posttranslational modifications on histone
3 (H3). Total HDAC activity was measured in four groups (AL, TRF, AL-SE and TRF-SE). There was a statistically significant decrease in HDAC activity in
TRF-subjected animals compared with that of AL-fed animals (A); additionally, the same result was observed in TRF-SE animals compared with that of AL-SE rats
(D). Representative immunoblots show that there was a significant increase in the acetylation of H3K9ac and H3K14ac in the nuclear extract from TRF rats
compared with that of AL-fed rats (B,C). Interestingly, the same results were observed in pilocarpine injected animals subjected to TRF compared with that of
pilocarpine-injected animals fed AL (E,F). Nuclear fraction samples were normalized with total H3 protein. Bar charts are the semiquantitative optical densities of
immunostained bands (B). Data are expressed as the mean ± SD from each determination (∗p < 0.05; ∗∗∗p < 0.001). The total activity assay is from four
independent animals and representative blots are from eight independent animals.
are similar; however, there is a significant difference at one
point of the early phase. In this regard, the early phase of the
analysis did not match with our behavioral studies, perhaps
because of intrinsic variations among individuals. Nevertheless, it
will be interesting to study this phenomenon more exhaustively.
Conversely, the TRF schedule produced a statistical reduction in
the power of the EEG recordings during the late phase compared
with AL-fed animals. In this sense, these analyses may explain the
reduction in seizure score found in the TRF group.
To date, there is no evidence showing that TRF might
have an anticonvulsant effect; however, it has been shown that
CR diminishes neuronal excitability and increases the after-
discharged threshold in an electrical stimulation seizure model
(Bough et al., 2003; Phillips-Farfán et al., 2015). In accordance
with this assumption, our results suggest that TRF may inhibit
seizure susceptibility and induce similar anticonvulsant effects in
the pilocarpine-induced SE.
As previously mentioned, dietary restriction (i.e., caloric
restriction) leads to a broad range of biochemical and metabolic
changes (Yuen and Sander, 2014). In the present work, we
demonstrated that TRF induces similar metabolic changes in the
hippocampus, as evidenced as an increase in the phosphorylation
of AMPK and a decrease in Akt kinase phosphorylation, which
might be relevant to inhibit or interfere with the mechanisms
involved in seizure generation. One possible explanation for the
anticonvulsant effect of TRF could be through the activation
of AMPK, which regulates mTOR (Laplante and Sabatini,
2012), a protein kinase that is closely related to the process
of epileptogenesis (Zeng et al., 2009; Nguyen et al., 2015).
In accordance, Phillips-Farfán et al. (2015) recently showed
an increase in AMPK phosphorylation and a decrease in
phospho-PKB (p-Akt), together with a decrease in phospho-S6
ribosomal protein in hippocampal homogenates in an electrical
kindling model. Interestingly, similar effects on mTOR kinase
downstream targets in the hippocampus were found using a KD
in a kainic acid-induced seizure model (McDaniel et al., 2011).
Although we did not study the activity of mTOR, changes in
the phosphorylation of both AMPK and Akt protein kinases
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measured in our study strongly suggest that the mTOR signaling
pathway could be inhibited during TRF, as seen in the CR
model. Interestingly, the same metabolic-related components
were found in peripheral organs, which correlated with a
decrease in liver weight with the production of ketone bodies
(Sengupta et al., 2010).
The role of ketonemia-induced by KDs in seizure control
is still controversial because high β-HB levels may or may not
confer seizure protection depending on the seizure-induction
model and rodent species (for a review, see Schoeler et al., 2013).
Nevertheless, there are many reports that have demonstrated
that β-HB correlated with improved seizure control, which is
considered to be a key feature of successful KD treatment
(Huttenlocher, 1976; Bough et al., 2003). In this regard, we
found a strong positive correlation between a high β-HB
concentration in the blood with prolonged seizure latency and
a negative correlation with the seizure severity score, supporting
the hypothesis that this ketone body has a significant role
in the anticonvulsant properties of metabolism-based therapies
(Yum et al., 2012; Yuen and Sander, 2014). However, it is clear
that this metabolite may not be the only factor involved in
the beneficial effects of metabolism-based diets shown in the
present work and others (Nguyen et al., 2015). It is possible that
other signaling components involved in metabolic regulation,
such as, insulin-like growth factor 1 (IGF-1), sirtuins (SIRTs),
AMPK and mTOR, may have an important role in these effects
and thus should be further investigated (Yuen and Sander,
2014).
As we mentioned before, TRF raises blood β-HB levels similar
to other metabolism-based diets. It is important to note that the
concentration of ketosis was not as high as that found in the
KD (0.88 mmol/L in TRF compared with 1.9 mmol/L produced
by the KD; Linard et al., 2010), suggesting that even though
this model induced moderate ketosis, it did not produce the
side effects found in other diets (Nei et al., 2014). According
to the literature, we hypothesize that the concentration of β-
HB induced by TRF might have an inhibitory effect on seizure
susceptibility. In this regard, it has recently been described that
β-HB has anticonvulsant effects on pilocarpine-induced seizures
in mice (Yum et al., 2012). A possible mechanism by which
β-HB exerts its effect could be mediated by increasing a shift
in the equilibrium of the aspartate-glutamate aminotransferase
reaction towards glutamate, thus allowing more glutamate to
become accessible to the glutamate decarboxylase enzyme and
favoring the synthesis of GABA (Daikhin and Yudkoff, 1998). In
addition, β-HB also decreases GABA-transaminase and GABA
transporter (GAT-1) gene expression in cultured astrocytes
whereby it could be another additional antiepileptic mechanism
by suppressing astrocytic GABA degradation (Suzuki et al.,
2009).
On the other hand, under pathological conditions, epigenetic
dynamics are thought to represent wide-scale alterations
in the expression of multiple genes (Grote et al., 2015).
Furthermore, it is well known that seizures can give rise to
enduring changes that reflect alterations in gene expression
patterns that contribute to the hallmarks of epilepsy (Roopra
et al., 2012). Currently, a few reports have studied specific
markers of epigenetic mechanisms in both acute seizures
and epilepsy models per se, and even more studies have
used a metabolism-based diet. In this regard, Kobow et al.
(2013) recently demonstrated that there is an increase in
DNA methylation during chronic rat epilepsy and that
these aberrant methylation patterns were inversely correlated
with gene expression changes. Moreover, the KD attenuated
seizure progression and ameliorated DNAmethylation mediated
changes in gene expression.
In the present study, we describe for the first time that a
TRF schedule can produce additional epigenetic modifications,
such as acetylation, on two lysine residues (9 and 14) of H3,
which are epigenetic tags associated with the activation of
gene transcription (Landgrave-Gómez et al., 2015). Such an
increase in these posttranslational modifications may be mainly
mediated by inhibiting histone deacetylase activity throughout
β-HB, an endogenous metabolite that is capable of inhibiting
HDAC (Shimazu et al., 2013), which is increased during dietary
restriction. The specific mechanism by which modifications on
H3 acetylation decrease the seizure susceptibility observed in
our results is still unknown. However, one possible explanation
could be through global changes in transcription, including genes
associated with the resistance to oxidative stress (Shimazu et al.,
2013), a pathological event that has been described to contribute
to epilepsy (Waldbaum and Patel, 2010). Nevertheless, more
studies are needed to elucidate this assumption in the TRF
model.
There is substantial research on the pros and cons of
continuous CR or intermittent fasting for the improvement of
health (Skaznik-Wikiel and Polotsky, 2014) which may be used
as a treatment in epilepsy refractory patients. However, our data
provide some rational evidence for using this type of diet as an
alternative therapy. This assumption may be considered because
it has been shown that intermittent fasting induces a transient
improvement in seizure control in children with an incomplete
response to a KD in a pilot trial (Hartman et al., 2013).
In summary, our study demonstrates that time restricted
feeding has an anticonvulsant effect in the pilocarpine-
seizure model. Furthermore, we suggest a possible scenario
in which restrictive diets may modulate the activity of the
main components of signaling pathways involved in energy
metabolism (i.e., AMPK and Akt signaling pathways) and
therefore increase the concentration of secondary metabolites
(such as β-HB), which may decrease the activity of proteins
capable of altering the chromatin structure (HDACs), in turn,
contributing in part to the beneficial effects of restrictive diets.
In this regard, our results support the interesting hypothesis
that some endogenous metabolites, such as β-HB, function
as a link between environmental cues with transcriptional
regulation and deepen our understanding of the molecular
mechanisms involved in the beneficial effects of restrictive
diets (calorie restriction or intermittent fasting) contributing
to seizure control. Finally, we hypothesize that TRF might
be considered in the future as an alternative therapeutic
tool together with antiepileptic drugs to control seizures in
pharmacoresistant epilepsy patients and accordingly improve
their quality of life.
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